ABBV - Cerevel Therapeutics jumps on report of Abbvie nearing $8B takeover
2023-12-06 16:06:57 ET
More on Cerevel Therapeutics
- Cerevel Stock Soars Ahead Of Parkinson's Drug Update - I'm On Sidelines
- Cerevel Therapeutics: High Standards And Development Burden Poses Reflexivity Risks
- Cerevel Therapeutics Holdings, Inc. (CERE) Q3 2023 Earnings Call Transcript
- Cerevel Therapeutics prices $450M stock
- Seeking Alpha’s Quant Rating on Cerevel Therapeutics
For further details see:
Cerevel Therapeutics jumps on report of Abbvie nearing $8B takeover